Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study. Issue 1 (December 2016)
- Record Type:
- Journal Article
- Title:
- Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study. Issue 1 (December 2016)
- Main Title:
- Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study
- Authors:
- Kim, Ryul
Ock, Chan-Young
Keam, Bhumsuk
Kim, Tae Min
Kim, Jin Ho
Paeng, Jin Chul
Kwon, Seong Keun
Hah, J. Hun
Kwon, Tack-Kyun
Kim, Dong-Wan
Wu, Hong-Gyun
Sung, Myung-Whun
Heo, Dae Seog - Abstract:
- Abstract Background The accuracy of18 F-fluorodeoxygluocose positron emission tomography/computed tomography (PET/CT) in predicting immediate failure after radical chemoradiotherapy (CRT) for HNSCC is poorly characterized at present. The purpose of this study was to examine PET/CT as a predictive and prognostic gauge of immediate failure after CRT and determine the impact of these studies on clinical decision making in terms of salvage surgery. Methods Medical records of 78 consecutive patients receiving radical CRT for locally advanced HNSCC were reviewed, analyzing PET/CTs done before and 3 months after CRT. Immediate failure was defined as residual disease or locoregional and/or systemic relapse within 6 months after CRT. Results Maximum standard uptake value (SUV) of post CRT PET/CT (postSUVmax) was found optimal for predicting immediate failure at a cutpoint of 4.4. Sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) were 90.0 %, 83.8 %, 98.3 %, and 45.0 %, respectively. Of 78 patients studied, postSUVmax ≥4.4 prevailed in 20 (25.6 %), with postSUVmax <4.4 in 58 (74.4 %). At postSUVmax ≥4.4 (vs. postSUVmax <4.4) OS was poorer by comparison (3-year OS: 56.9 vs. 87.7 %;P = 0.005), as was progression-free survival (3-year PFS: 42.9 vs. 81.1 %;P < 0.001). At postSUVmax ≥4.4, OS with and without immediate salvage surgery did not differ significantly (3-year OS: 60.0 vs. 55.6 %; Log-rankP = 0.913). Conclusion Post CRT PET/CTAbstract Background The accuracy of18 F-fluorodeoxygluocose positron emission tomography/computed tomography (PET/CT) in predicting immediate failure after radical chemoradiotherapy (CRT) for HNSCC is poorly characterized at present. The purpose of this study was to examine PET/CT as a predictive and prognostic gauge of immediate failure after CRT and determine the impact of these studies on clinical decision making in terms of salvage surgery. Methods Medical records of 78 consecutive patients receiving radical CRT for locally advanced HNSCC were reviewed, analyzing PET/CTs done before and 3 months after CRT. Immediate failure was defined as residual disease or locoregional and/or systemic relapse within 6 months after CRT. Results Maximum standard uptake value (SUV) of post CRT PET/CT (postSUVmax) was found optimal for predicting immediate failure at a cutpoint of 4.4. Sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) were 90.0 %, 83.8 %, 98.3 %, and 45.0 %, respectively. Of 78 patients studied, postSUVmax ≥4.4 prevailed in 20 (25.6 %), with postSUVmax <4.4 in 58 (74.4 %). At postSUVmax ≥4.4 (vs. postSUVmax <4.4) OS was poorer by comparison (3-year OS: 56.9 vs. 87.7 %;P = 0.005), as was progression-free survival (3-year PFS: 42.9 vs. 81.1 %;P < 0.001). At postSUVmax ≥4.4, OS with and without immediate salvage surgery did not differ significantly (3-year OS: 60.0 vs. 55.6 %; Log-rankP = 0.913). Conclusion Post CRT PET/CT imaging has prognostic value in terms of OS and PFS and is useful in predicting immediate therapeutic failure, given its high NPV. However, OS was not significantly altered by early salvage surgery done on the basis of post CRT PET/CT findings. … (more)
- Is Part Of:
- BMC cancer. Volume 16:Issue 1(2016)
- Journal:
- BMC cancer
- Issue:
- Volume 16:Issue 1(2016)
- Issue Display:
- Volume 16, Issue 1 (2016)
- Year:
- 2016
- Volume:
- 16
- Issue:
- 1
- Issue Sort Value:
- 2016-0016-0001-0000
- Page Start:
- 1
- Page End:
- 9
- Publication Date:
- 2016-12
- Subjects:
- Head and neck cancer -- PET/CT -- Salvage surgery -- Concurrent chemoradiotherapy -- Survival
Cancer -- Periodicals
616.994005 - Journal URLs:
- http://www.biomedcentral.com/bmccancer/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=16 ↗
http://link.springer.com/ ↗ - DOI:
- 10.1186/s12885-016-2147-y ↗
- Languages:
- English
- ISSNs:
- 1471-2407
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 9969.xml